Genprex, Inc.
GNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $13 | $69 | $62 |
| - Cash | $2 | $7 | $21 | $39 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $6 | $49 | $23 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$21 | -$31 | -$24 | -$21 |
| % Margin | – | – | – | – |
| Net Income | -$21 | -$31 | -$24 | -$21 |
| % Margin | – | – | – | – |
| EPS Diluted | -266.954 | -1,128 | -990 | -877.5 |
| % Growth | 76.3% | -13.9% | -12.8% | – |
| Operating Cash Flow | -$17 | -$25 | -$18 | -$14 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$17 | -$25 | -$18 | -$14 |